Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Laura, Sighinolfi"'
Autor:
Martina Maritati, Trentini Alessandro, Nunzia Zanotta, Manola Comar, Tiziana Bellini, Laura Sighinolfi, Carlo Contini
Publikováno v:
AIDS Research and Therapy, Vol 17, Iss 1, Pp 1-7 (2020)
Abstract Background Although HIV-related deaths have decreased dramatically following the introduction of antiretroviral therapy (ART), HIV infection itself causes increased morbidity and mortality for both non-AIDS-related events or chronic inflamma
Externí odkaz:
https://doaj.org/article/79979ba4f8ee47a8b3344161f5e89e33
Autor:
Milensu Shanyinde, Enrico Girardi, Massimo Puoti, Andrea De Luca, Laura Sighinolfi, Uberti Foppa Caterina, Pietro Caramello, Fiona C. Lampe, Antonella D’Arminio Monforte, Alessandro Cozzi-Lepri, for the ICONA Foundation Study Group
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-13 (2019)
Abstract Background Alcohol consumption is a known risk factor for liver disease in HIV-infected populations. Therefore, knowledge of alcohol consumption behaviour and risk of disease progression associated with hazardous drinking are important in th
Externí odkaz:
https://doaj.org/article/3bf4fae4a7754aea98e4d74f4e7c61e5
Autor:
Antonella Tripiciano, Orietta Picconi, Sonia Moretti, Cecilia Sgadari, Aurelio Cafaro, Vittorio Francavilla, Angela Arancio, Giovanni Paniccia, Massimo Campagna, Maria Rosaria Pavone-Cossut, Laura Sighinolfi, Alessandra Latini, Vito S. Mercurio, Massimo Di Pietro, Francesco Castelli, Annalisa Saracino, Cristina Mussini, Giovanni Di Perri, Massimo Galli, Silvia Nozza, Fabrizio Ensoli, Paolo Monini, Barbara Ensoli
Publikováno v:
EBioMedicine, Vol 66, Iss , Pp 103306- (2021)
Background: Low-level HIV viremia originating from virus reactivation in HIV reservoirs is often present in cART treated individuals and represents a persisting source of immune stimulation associated with sub-optimal recovery of CD4+ T cells. The HI
Externí odkaz:
https://doaj.org/article/347c39a646b64210952c288b56fdfe12
Autor:
Mario Luca Morieri, Viola Guardigni, Juana Maria Sanz, Edoardo Dalla Nora, Cecilia Soavi, Giovanni Zuliani, Laura Sighinolfi, Angelina Passaro
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Metabolic and cardiovascular diseases (CVD) represent a major problem in HIV infection. The aim of this study was to evaluate the relationship of HIV infection and antiretroviral therapy (ART) with circulating levels of two adipok
Externí odkaz:
https://doaj.org/article/0aaf956b69c74609b19bb04d5858bda0
Autor:
Paolo Maggi, Antonio Di Biagio, Stefano Rusconi, Stefania Cicalini, Maurizio D’Abbraccio, Gabriella d’Ettorre, Canio Martinelli, Giuseppe Nunnari, Laura Sighinolfi, Vincenzo Spagnuolo, Nicola Squillace
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-17 (2017)
Abstract Background Aim of this review is to focus the attention on people living with HIV infection at risk of developing a cardiovascular event. What is or what would be the most suitable antiretroviral therapy? Which statin or fibrate to reduce th
Externí odkaz:
https://doaj.org/article/15eb967716134a30a38ffc4f17cd1671
Autor:
Cecilia Sgadari, Paolo Monini, Antonella Tripiciano, Orietta Picconi, Anna Casabianca, Chiara Orlandi, Sonia Moretti, Vittorio Francavilla, Angela Arancio, Giovanni Paniccia, Massimo Campagna, Stefania Bellino, Marianna Meschiari, Silvia Nozza, Laura Sighinolfi, Alessandra Latini, Antonio Muscatello, Annalisa Saracino, Massimo Di Pietro, Massimo Galli, Aurelio Cafaro, Mauro Magnani, Fabrizio Ensoli, Barbara Ensoli
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Introduction: Tat, a key HIV virulence protein, has been targeted for the development of a therapeutic vaccine aimed at cART intensification. Results from phase II clinical trials in Italy (ISS T-002) and South Africa (ISS T-003) indicated that Tat v
Externí odkaz:
https://doaj.org/article/c78e740c80274a2887513b75affaebd7
Autor:
Elena Raffetti, Maria Concetta Postorino, Francesco Castelli, Salvatore Casari, Filippo Castelnuovo, Franco Maggiolo, Elisa Di Filippo, Alessandro D’Avino, Andrea Gori, Nicoletta Ladisa, Massimo Di Pietro, Laura Sighinolfi, Fabio Zacchi, Carlo Torti
Publikováno v:
BMC Public Health, Vol 16, Iss 1, Pp 1-10 (2016)
Abstract Background We aimed at evaluating frequency and factors associated with late presentation and advanced HIV disease and excess risk of death due to these conditions from 1985 to 2013 among naïve HIV infected patients enrolled in the Italian
Externí odkaz:
https://doaj.org/article/36e825e0f9154243a973cccdb713b6fa
Autor:
Alice Toschi, Eleonora Salsi, Gabriella Verucchi, Gabriele Fabbri, Laura Sighinolfi, Francesco Cristini, Viola Guardigni, Gianluca Cuomo, Lorenzo Badia, Pierluigi Viale, Marco Massari, Elena Rosselli Del Turco
Publikováno v:
AIDS. 35:1967-1972
OBJECTIVES: Hepatocellular carcinoma (HCC) has become a major issue in coinfected HIV/HCV patients with liver cirrhosis. We aimed to determine the rate of HCC occurrence after a direct-acting antiviral (DAA) treatment and to evaluate the factors asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d1660faf866dbaf9959269ae34aeefd
https://doi.org/10.1097/qad.0000000000002973
https://doi.org/10.1097/qad.0000000000002973
Autor:
Ada Bertoli, Michael P. Manns, M. Katja Deterding, Vanni Borghi, Silvia Barbaliscia, Elisabetta Degasperi, Julian Schulze zur Wiesch, Velia Chiara Di Maio, Ansgar W. Lohse, Wolfgang Schmidt, Markus Cornberg, Christophe Moreno, Tomas Beyer, Federico García, Johannes Vermehren, Pietro Lampertico, Andreas E. Kremer, Laura Sighinolfi, Felix Piecha, Magdalena Lara, Pier Luigi Toniutto, Christoph Sarrazin, Antonio Craxì, Francesca Ceccherini-Silberstein, Jonas Schreiber, Jesús Santos, Ana Belén Pérez, Alessio Aghemo, William Gennari, Lorenzo Magenta, Manuel Alberto Macias Rodriguez, Heiner Wedermeyer, Ana Fuentes, Stephan Grunwald, Jose Miguel Rosales Zabal, Francisco Téllez, Dolores Merino, Burkhard Jäger, Miguel García Deltoro, Juan Manuel Pascasio-Acevedo, Blanca Figueruela, Andreas Stallmach, Renate Heyne, Valeria Ghisetti, Christoph P. Berg, Carlo Federico Perno, Elisa Fernández-Fuertes, Nikolaus Kordecki, Ana María Martinez Sapiña, Natalia Chueca, Andreas Herrmann, Eva Jägel-Guedes, Vincenza Calvaruso, Maurizio Zazzi, Massimo Andreoni, Lucio Boglione, Mario Angelico, Simona Francioso, Giuseppe Cariti, Cristina Quilez, Tiziano Allice, Christiana Graf, Leopoldo Muñoz-Medina, Fausto Baldanti, Rudolf E. Stauber, Jürgen Siebler, Julia Dietz, Maria Josefa Rodriguez Pardo, Kerstin Port, Heinz Zoller, Juan Carlos Alados, Stefan Zeuzem, Juan Ignacio Arenas Ruiz-Tapiador, Joaquín Cabezas, Stefania Paolucci, Axels Baumgarten, Kai-Henrik Peiffer, Adolfo de Salazar, Pietro Pozzoni, Miguel Jimenez, Hjördis Möller
Publikováno v:
Journal of Hepatology. 74:801-810
Background & Aims There are limited data on patients with chronic HCV infection in whom combination voxilaprevir (VOX), velpatasvir (VEL), sofosbuvir (SOF) retreatment fails. Thus, we aimed to assess treatment failure and rescue treatment options in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88cd0ab9dd512362a11eac31e987e6ab
https://doi.org/10.1016/j.jhep.2020.11.017
https://doi.org/10.1016/j.jhep.2020.11.017
Autor:
Giuseppe Lapadula, Davide Paolo Bernasconi, Salvatore Casari, Franco Maggiolo, Roberto Cauda, Massimo Di Pietro, Nicoletta Ladisa, Laura Sighinolfi, Sarah Dal Zoppo, Francesca Sabbatini, Alessandro Soria, Chiara Pezzoli, Annalisa Mondi, Silvia Costarelli, Maria Grazia Valsecchi, Carlo Torti, Andrea Gori, Italian MASTER cohort
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0162320 (2016)
BACKGROUND:Tenofovir (TDF) can cause kidney injury through tubular dysfunction, with or without drop of estimated glomerular filtration rate (eGFR). Whether mild eGFR reductions during treatment should be considered a reason for prompt TDF discontinu
Externí odkaz:
https://doaj.org/article/078bb9ca78124897ada2cb4525d4d297